Followers | 110 |
Posts | 20257 |
Boards Moderated | 0 |
Alias Born | 05/08/2008 |
Thursday, March 21, 2019 8:11:07 AM
At current OS plus 2M for investor Warrants and Pref Es which are now all issued (future known dilution), we can start with a round 8M shares to calculate the the annual sales. For a company growing at a rate of 30%/yr (an optimistic value at this time, since sales are declining), a market cap to sales ratio of 5X, I'm assuming. $10 PPS X 8M = $80M mkt cap. $80M / 5 multiplier = $16M in sales revenue. Given that sales aren't growing yet, the 5 multiplier would actually be 1X or even less. Plus nothing has been added for conversions of Rich's Pref C/Ds (will at least double OS overnight), nor for shares issued to buy Green Grow (totally unknown at this time). All these things considered, sales might have to be $800M to $1B to hit $10 PPS by end of this year.
Your Question 2: "All the news is great! How much time does the company have to grow sales and revenue from their various intiatives?"
Much of the news is great and much of that hasn't yet occurred. The four sources of extra dilution are not great, especially 2 of them since they add no shareholder value, only enrich Rich. As far as how much time do they have ...years I guess. He's spent 14 so far since inception of Iconic in 2005 and has only $20M in cumulative losses (according to his audited fins) to show for it. Hempology will be his 10th product. It's a growing market, so it could pan out for him. Until he stops the excessive dilution, I'm not seeing it panning out for shareholders. But he might cancel the Pref C/Ds an not issue shares if he changes his mind from what was in PR earlier this week.
Recent ICNB News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/29/2023 09:21:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 12:51:54 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM